Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for Sleep and Circadian Function in Pediatric Atopic Dermatitis
NCT05042258Phase 4Recruiting
- Sponsor
- Northwestern University
- Start
- Aug 2024
- Primary completion
- Jun 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in atopic dermatitis (AD), sponsored by Northwestern University. Started Aug 2024; status: recruiting.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05042258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05042258.